Liposomal Glutathione
Pre-Clinically Tested for Enhanced Oral Bioavailability
Powered by Advanced LIPOZOID Liposomal Technology for Superior Absorption & Efficacy
Glutathione is a powerful intracellular antioxidant critical for detoxification, immune support, and cellular health. However, its oral bioavailability is traditionally limited due to degradation in the gastrointestinal tract.
Using proprietary LIPOZOID™ liposomal delivery technology, we have developed a liposomal glutathione formulation that overcomes conventional absorption challenges by encapsulating glutathione in nanosized liposomes, enabling enhanced stability and efficient cellular delivery.
Key Highlights
-
Proprietary Liposomal Delivery
LIPOZOID™ ensures glutathione is protected from degradation in the GI tract and facilitates direct transport across the intestinal barrier.
-
Proven Higher Bioavailability
In pre-clinical pharmacokinetic studies, our liposomal glutathione exhibited:
16.6% higher bioavailability compared to native glutathione
Improved systemic absorption and faster onset of action
-
Nanoparticle Size Range:
liposome size: 203 nm – ensuring optimal absorption and enhanced cellular penetration.
-
Good Zeta Potential Stability :
The zeta potential of our liposomes ensures electrostatic repulsion, preventing aggregation and enhancing stability in suspension. This results in a longer shelf life and better dispersibility in physiological conditions

Pharmacokinetic parameters of L-Glutathione reduced and Liposomal Glutathione 40% in male wistar rats
PHARMACOKINETIC PROFILE

PHARMACOKINETIC PROFILE

TEM IMAGE OF LIPOSOMAL GLUTATHIONE

Applications
CAPSULES

TABLETS

GUMMIES

SOLIDBEVERAGES
